Article
Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
Carcinogenesis - 1 Jun 1997
London S J, Daly A K, Leathart J B, Navidi W C, Carpenter C C, Idle J R
Abstract excerpt
The well described genetic polymorphism of the CYP2D6 gene influences response to a wide variety of therapeutic agents metabolized by the CYP2D6 enzyme product. CYP2D6 also appears to play a role, along with other cytochrome P450 enzymes, in the metabolic activation of the tobacco specific nitrosamine, NNK, as well as metabolism of nicotine to cotinine. While impaired activity of CYP2D6 was strongly protective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
